Publix Q1 Sales Rise 2%, While Earnings Fall on Drug Pricing Impact

Publix posted higher first-quarter sales but lower earnings, as the grocer said a Medicare drug pricing change weighed on results.

For the three months ended March 28, 2026, Publix reported sales of $16.1 billion, up 2% from $15.8 billion a year earlier. Comparable-store sales were flat.

The company said the sales increase was dampened by the Medicare maximum fair price change that took effect Jan. 1, 2026, lowering prices for 10 drugs and reducing...

Growth Continues for Publix with Rising Sales, Earnings, and Stock Value

Publix’s sales for the second quarter rose 7.3%, increasing from $14.5 billion to $15.6 billion. Comparable store sales were also up, growing 6% during the quarter. The company estimates that approximately 1% of the year-over-year sales growth in Q2 was due to the timing of the Easter holiday, which fell in the second quarter of 2025 but in the first quarter of 2024.

Net earnings for the quarter increased 41.5% to $1.4 billion, compared to...

Executives from Kroger, Publix, Sysco and Walmart Join GS1 US Board of Governors

The GS1 US Board of Governors has elected four industry leaders to join the GS1 US Board: Benjamin Hamilton, vice president, supply chain planning, Kroger; Brad Oliver, senior vice president of product business development, Publix Super Markets, Inc.; Greg Keller, senior vice president, national accounts, Sysco, SYGMA, and Guest Worldwide; and Greg Cathey, senior vice president, transformation and innovation, Walmart. Additionally, Brian Dick, president and CEO, Golden State Foods, has been appointed vice chairman.

These executives comprise a cross-industry Board of Governors...